| SpectraBase Spectrum ID |
2nqTsmxP0TI |
| Name |
MDMB-FUB7AICA TMS |
| Classification |
Azaindolecarboxamide cannabinoid designer drug derivative |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
469.219696597 u |
| Formula |
C25H32FN3O3Si |
| InChI |
InChI=1S/C25H32FN3O3Si/c1-25(2,3)21(24(31)32-4)29(33(5,6)7)23(30)20-16-28(22-19(20)9-8-14-27-22)15-17-10-12-18(26)13-11-17/h8-14,16,21H,15H2,1-7H3 |
| InChIKey |
MJXQPYVNAZQZOD-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
469.632 g/mol |
| Nominal Mass |
469 u |
| Quality |
980 |
| Retention Index |
3595 |
| SMILES |
C(N(C(C=1C=2C(N(C1)CC1=CC=C(C=C1)F)=NC=CC2)=O)[Si](C)(C)C)(C(C)(C)C)C(OC)=O |
| SPLASH |
splash10-0zfr-2691300000-d71baa4021edeea3888f |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
methyl 2-(((1-(4-fluorobenzyl)-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl)(trimethylsilyl)amino)-3,3-dimethylbutanoate |
| Technique |
GC/MS |
| Wiley ID |
DD2024_027356 |
